Distribution of species, serotype, and antimicrobial resistance of Shigella spp. in patients from the Metropolitan Area of Paraguay (2019-2025)
DOI:
https://doi.org/10.31698/ped.53012026002Keywords:
Shigella, infectious diarrhea, epidemiological surveillance, antimicrobial resistance, ParaguayAbstract
Introduction: Shigellosis is an acute infection caused by bacteria of the genus Shigella, with high prevalence in pediatric populations. Surveillance allows the identification of serotypes and resistance patterns, improving clinical and epidemiological management.
Objective: To determine the distribution of species, serotypes, and antimicrobial resistance of Shigella spp. in the metropolitan area of Paraguay (2019–2025).
Methods: A cross-sectional descriptive observational study was conducted on 610 clinical bacterial isolates received by the Central Public Health Laboratory of the Enteropathogen Network. Species, serotypes, and resistance profiles were identified following standardized protocols. Data were processed in Microsoft Excel® and analyzed using descriptive statistics.
Results: Pediatric cases predominated (69.8%). Shigella sonnei (67.2%) and Shigella flexneri (32.8%) were identified. Among 155 strains of S. flexneri, the most frequent serotype was 2a (63.2%). Observed resistance was trimethoprim-sulfamethoxazole 62.6%, ampicillin 39.7%, and azithromycin 13.4%. Intermediate resistance was found to ciprofloxacin 19.4% and azithromycin 21.3%.
Conclusions: The study demonstrated the prevalence of S. sonnei and serotype 2a of S. flexneri, along with resistance patterns that compromise commonly used antibiotics. These findings reinforce the need to maintain active laboratory surveillance, update therapeutic guidelines, and strengthen control strategies against resistant strains, with direct impact on public health and clinical management of shigellosis in Paraguay.
References
Rogawski McQuade ET, Liu J, Mahfuz M, Havt A, Varghese T, Shrestha J, et al. Epidemiology of Shigella species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study. Lancet Microbe. 2025;6(6):101064. doi: 10.1016/j.lanmic.2024.101064
Lubeck-Schricker M, Rivas-Nieto AC, Rosauer J, Mpinganjira S, Malhotra A, Bastias M, et al. Burden of Shigella among children with diarrhea in the Americas: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025;19(8):e0013393. doi: 10.1371/journal.pntd.0013393
Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2018;391(10122):801-12. doi: 10.1016/S0140-6736(17)33296-8
Pakbin B, Brück WM, Brück TB. Molecular mechanisms of Shigella pathogenesis; recent advances. Int J Mol Sci. 2023;24:2448. doi: 10.3390/ijms24032448
Bennish ML, Ahmed S. Shigellosis. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP, editors. Hunter’s Tropical Medicine and Emerging Infectious Diseases. 10th ed. London: Elsevier; 2020. p. 492-9. doi: 10.1016/B978-0-323-55512-8.00048-X
Zhao Z, Yang M, Lv J, Hu Q, Chen Q, Lei Z, et al. Shigellosis seasonality and transmission characteristics in different areas of China: a modelling study. Infect Dis Model. 2022;7(2):161-78. doi: 10.1016/j.idm.2022.05.003
Nasser A, Mosadegh M, Azimi T, Shariati A. Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population. Mol Cell Pediatr. 2022;9(1):12. doi: 10.1186/s40348-022-00145-z
Ashida H, Suzuki T, Sasakawa C. Shigella infection and host cell death: a double-edged sword for the host and pathogen survival. Curr Opin Microbiol. 2021;59:1-7. doi: 10.1016/j.mib.2020.07.007
Salleh MZ, Nik Zuraina NM, Hajissa K, Ilias MI, Banga Singh KK, Deris ZZ. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase-producing Shigella species in Asia: a systematic review and meta-analysis. Antibiotics. 2022;11:1653. doi: 10.3390/antibiotics11121653
Nuzhat S, Das R, Das S, Islam S Bin, Palit P, Haque MA, et al. Antimicrobial resistance in shigellosis: a surveillance study among urban and rural children over 20 years in Bangladesh. PLoS One. 2022;17(11):e0277574. doi: 10.1371/journal.pone.0277574
Scott TA, Baker KS, Trotter C, Jenkins C, Mostowy S, Hawkey J, et al. Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions. Nat Rev Microbiol. 2025;23(5):303-17. doi: 10.1038/s41579-024-01126-x
Huber C, Orrego MV, Ortiz F, Alvarez M, Weiler N. Prevalencia de patógenos causantes de enfermedad diarreica aguda en el área Metropolitana de Asunción y Central. Rev Salud Publica Parag. 2019;9(2):41–5. doi: 10.18004/rspp.2019.diciembre.41-45
Caradonna V, Hunyady A, Nakakana U, Iturriza M, Micoli F, Rossi O, et al. Shigella sonnei and Shigella flexneri: epidemiology supporting development of cross-protective vaccines. Hum Vaccin Immunother. 2026;22(1). doi: 10.1080/21645515.2025.2603736
Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, et al. Global phylogeography and evolutionary history of Shigella dysenteriae type 1. Nat Microbiol. 2016;1(4):16027. doi: 10.1038/nmicrobiol.2016.27
Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, et al. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002;30(20):4432-41. doi: 10.1093/nar/gkf566
Gabor CE, Hazen TH, Delaine-Elias BC, Rasko DA, Barry EM. Genomic, transcriptomic, and phenotypic differences among archetype Shigella flexneri strains of serotypes 2a, 3a, and 6. mSphere. 2023;8(6):e0040823. doi: 10.1128/msphere.00408-23
Yang C, Xiang Y, Qiu S. Resistance in enteric Shigella and nontyphoidal Salmonella: emerging concepts. Curr Opin Infect Dis. 2023;36(5). doi: 10.1097/QCO.0000000000000960
World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1 [Internet]. Geneva: WHO; 2005 [citado 2026 Mar 2]. Disponible en: https://www.who.int/publications/i/item/9241592330
Chung The H, Bodhidatta L, Pham DT, Mason CJ, Ha Thanh T, Voong Vinh P, et al. Evolutionary histories and antimicrobial resistance in Shigella flexneri and Shigella sonnei in Southeast Asia. Commun Biol. 2021;4(1):353. doi: 10.1038/s42003-021-01905-9
Asad A, Jahan I, Munni MA, Begum R, Mukta MA, Saif K, et al. Multidrug-resistant conjugative plasmid carrying mphA confers increased antimicrobial resistance in Shigella. Sci Rep. 2024;14(1):6947. doi: 10.1038/s41598-024-57423-1
Blake KS, Xue YP, Gillespie VJ, Fishbein SRS, Tolia NH, Wencewicz TA, et al. The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. Nat Commun. 2025;16:1452. doi: 10.1038/s41467-025-56425-5
Baumgart S, Phan T, McKew G. Epidemiology and antimicrobial resistance rates for Shigella species in a resource-rich setting. Pathology. 2025;57(1):94–9. doi: 10.1016/j.pathol.2024.07.004
Pan American Health Organization. Red PulseNet América Latina y el Caribe (PNALC) [Internet]. Washington, DC: PAHO; 2023 [citado 2026 Mar 2]. Disponible en: https://www.paho.org/es/red-pulsenet-america-latina-caribe-pnalc
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pediatría (Asunción)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo el contenido de este sitio está bajo una Licencia de Atribución Creative Commons.
Todo el contenido de esta revista se encuentra disponible bajo una Licencia Creative Commons Atribución, promoviendo el acceso abierto, la difusión y la preservación del conocimiento científico.